A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)
Status:
Terminated
Trial end date:
2017-09-29
Target enrollment:
Participant gender:
Summary
THIS IS THE SECOND PART OF A 2-PART STUDY. The purpose of the first part of this study was to
determine the safety and tolerability of ascending doses of valproic acid (also known as
Depacon) administered as intravenous infusion (IV) in doses ranging from 15 mg/kg to 250
mg/kg in healthy subjects.
ID: VPA-C-002
The second part of the study will also be to determine the safety and tolerability of single
ascending doses of valproic acid administered as IV in trauma subjects with hemorrhagic
shock.